RETRACTED: Syzygium aqueum: A Polyphenol- Rich Leaf Extract Exhibits Antioxidant, Hepatoprotective, Pain-Killing and Anti-inflammatory Activities in Animal Models
A Retraction of the Original Research article
Syzygium aqueum: A polyphenol- rich leaf extract exhibits antioxidant, hepatoprotective, pain-killing and anti-inflammatory activities in animal models
by Sobeh M, Mahmoud MF, Petruk G, Rezq S, Ashour ML, Youssef FS, El-Shazly AM, Monti DM, Abdel-Naim AB and Wink M (2018). Front. Pharmacol. 9:566. doi: 10.3389/fphar.2018.00566
The Journal retracts the 5 June 2018 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication was identified in Figure 5. The image in this article also appeared in two other articles with common authors which described the rats as Male Sprague-Dawley rats [in (Frontiers in Pharmacology (2018), doi: 10.3389/fphar.2018.00566) and (Food and Chemical Toxicology (2018), doi: 10.1016/j.fct.2018.01.031]) and as Male Wistar rats [in (Pharmaceuticals (2020), doi: 10.3390/ph13050084)]. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.
Citation: Frontiers Editorial Office (2024) Retraction: Syzygium aqueum: A polyphenol- rich leaf extract exhibits antioxidant, hepatoprotective, pain-killing and anti-inflammatory activities in animal models. Front. Pharmacol. 15:1515827. doi: 10.3389/fphar.2024.1515827
Received: 23 October 2024; Accepted: 23 October 2024;
Published: 29 October 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org